Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients. (2019)
Attributed to:
Disease mechanisms and therapy for inherited disorders of the neuromuscular synapse.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci.insight.127167
PubMed Identifier: 31217355
Publication URI: http://europepmc.org/abstract/MED/31217355
Type: Journal Article/Review
Volume: 4
Parent Publication: JCI insight
Issue: 12
ISSN: 2379-3708